| NCT ID | NCT05954299 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Vincere Cancer Center |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2023-07-18 |
| Primary Completion | 2033-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2023-07-18 with a primary completion date of 2033-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Vincere Biobank aims to make quality biospecimens and associated clinical data available for research studies related to advancing medicine and improving care for patients, including cancer screening, treatment, and care.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or older; any gender * Able to donate a blood, urine, tissue, and/or other biospecimen sample * Able to provide informed consent to participate in the study Exclusion Criteria: * Minors, under the age of 18 years * Individuals who lack the capacity to give informed consent
Contact & Investigator
Vershalee Shukla, MD
PRINCIPAL INVESTIGATOR
Vincere Cancer Center
Frequently Asked Questions
Who can join the NCT05954299 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05954299 currently recruiting?
Yes, NCT05954299 is actively recruiting participants. Contact the research team at drlau@vincerecancer.com for enrollment information.
Where is the NCT05954299 trial being conducted?
This trial is being conducted at Scottsdale, United States.
Who is sponsoring the NCT05954299 clinical trial?
NCT05954299 is sponsored by Vincere Cancer Center. The principal investigator is Vershalee Shukla, MD at Vincere Cancer Center. The trial plans to enroll 5,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.